Health Canada Examining Information Linking Bristol-Myers Squibb Company's (Jobs) Antiviral Drug To Development Of Treatment-Resistant HIV

Published: Feb 21, 2007

OTTAWA, Feb. 21 /CNW Telbec/ - Health Canada is informing Canadians of new information submitted by the manufacturer of the antiviral drug Baraclude that suggests the drug may be linked to the development of a treatment-resistant strain of HIV in one patient with HIV.

>>> Discuss This Story

Back to news